Back to Search Start Over

Hydrogen Sulfide Delivery to Enhance Bone Tissue Engineering Cell Survival.

Authors :
Ali Akbari Ghavimi, Soheila
Faulkner, Trent J.
Tata, Rama Rao
Hemmerla, August J.
Huddleston, Samantha E.
Rezaei, Farnoushsadat
Lungren, Ethan S.
Zhang, Rui
Bumann, Erin E.
Ulery, Bret D.
Source :
Pharmaceuticals (14248247); May2024, Vol. 17 Issue 5, p585, 16p
Publication Year :
2024

Abstract

Though crucial for natural bone healing, local calcium ion (Ca<superscript>2+</superscript>) and phosphate ion (P<subscript>i</subscript>) concentrations can exceed the cytotoxic limit leading to mitochondrial overload, oxidative stress, and cell death. For bone tissue engineering applications, H<subscript>2</subscript>S can be employed as a cytoprotective molecule to enhance mesenchymal stem cell (MSC) tolerance to cytotoxic Ca<superscript>2+</superscript>/P<subscript>i</subscript> concentrations. Varied concentrations of sodium hydrogen sulfide (NaSH), a fast-releasing H<subscript>2</subscript>S donor, were applied to assess the influence of H<subscript>2</subscript>S on MSC proliferation. The results suggested a toxicity limit of 4 mM for NaSH and that 1 mM of NaSH could improve cell proliferation and differentiation in the presence of cytotoxic levels of Ca<superscript>2+</superscript> (32 mM) and/or P<subscript>i</subscript> (16 mM). To controllably deliver H<subscript>2</subscript>S over time, a novel donor molecule (thioglutamic acid—GluSH) was synthesized and evaluated for its H<subscript>2</subscript>S release profile. Excitingly, GluSH successfully maintained cytoprotective level of H<subscript>2</subscript>S over 7 days. Furthermore, MSCs exposed to cytotoxic Ca<superscript>2+</superscript>/P<subscript>i</subscript> concentrations in the presence of GluSH were able to thrive and differentiate into osteoblasts. These findings suggest that the incorporation of a sustained H<subscript>2</subscript>S donor such as GluSH into CaP-based bone graft substitutes can facilitate considerable cytoprotection, making it an attractive option for complex bone regenerative engineering applications. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14248247
Volume :
17
Issue :
5
Database :
Complementary Index
Journal :
Pharmaceuticals (14248247)
Publication Type :
Academic Journal
Accession number :
177491889
Full Text :
https://doi.org/10.3390/ph17050585